Citigroup
AAPG icon

Citigroup’s Ascentage Pharma AAPG Stock Holding History

Citigroup’s Portfolio AAPG Stock Details AAPG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$17 Buy
+1
New +$18 ﹤0.01% 5768

Other funds holding AAPG

Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
EverSource Wealth Advisors
EverSource Wealth Advisors Birmingham, Alabama $3.11B AUM 21.48% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Citigroup's AAPG Position: Q3 2026 in Review

Citigroup opened a new position in Ascentage Pharma (AAPG) in Q3 2026: 1 share worth $17. The stake represents ﹤0.01% of the portfolio and ranks #5768 among its holdings.

5 funds tracked by Wall St. Rank hold AAPG as of Q3 2026.

  • Citigroup held 1 share of Ascentage Pharma worth $17 as of Q3 2026.
  • Ascentage Pharma was a new Citigroup position in Q3 2026.
  • Ascentage Pharma made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5768 holding.
  • 5 funds tracked by Wall St. Rank held Ascentage Pharma as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.